Literature DB >> 24780515

Chronic kidney disease in type 2 diabetes: lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study.

G Pugliese1, A Solini2, E Bonora3, C Fondelli4, E Orsi5, A Nicolucci6, G Penno2.   

Abstract

The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study is an ongoing observational survey that examines the role of estimated glomerular filtration rate (eGFR) as an independent predictor of cardiovascular and renal outcomes in 15,773 Italian subjects with type 2 diabetes. The analysis of data collected at the enrollment visit provided a picture of chronic kidney disease (CKD) and its association with other complications, risk factors for cardiovascular disease (CVD) and treatments in a large contemporary cohort. Main results of this analysis were that (a) non-albuminuric renal impairment is the predominant clinical phenotype in patients, particularly women, with reduced eGFR; (b) concordance between CKD and diabetic retinopathy is low, with only a minority of patients with renal dysfunction presenting with any or advanced retinal lesions; (c) the non-albuminuric form is associated with a significant prevalence of CVD, especially at the level of the coronary vascular bed; (d) CKD is associated with hemoglobin (Hb) A1c variability more than with average HbA1c, whereas retinopathy and CVD are not; (e) in elderly individuals with moderate-to-severe eGFR reduction, use of agents which are not recommended, such as sulphonylureas and metformin, is still frequent; and (f) though complications are generally more prevalent in men (except non-albuminuric renal impairment) women show a less favorable CVD risk profile and achieve therapeutic targets to a lesser extent than men, despite the fact that treatment intensity is not lower. These data update existing information on the natural history of CKD in patients with type 2 diabetes.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Albuminuria; Cardiovascular disease; Chronic kidney disease; Diabetic retinopathy; Type 2 diabetes; eGFR

Mesh:

Substances:

Year:  2014        PMID: 24780515     DOI: 10.1016/j.numecd.2014.02.013

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  16 in total

1.  Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program.

Authors:  Brendon L Neuen; Toshiaki Ohkuma; Bruce Neal; David R Matthews; Dick de Zeeuw; Kenneth W Mahaffey; Greg Fulcher; Qiang Li; Meg Jardine; Richard Oh; Hiddo L Heerspink; Vlado Perkovic
Journal:  J Am Soc Nephrol       Date:  2019-09-17       Impact factor: 10.121

2.  Type 2 diabetes treatment and progression of chronic kidney disease in Italian family practice.

Authors:  G Ermini; C Tosetti; D Zocchi; M Mandreoli; M T Caletti; G Marchesini
Journal:  J Endocrinol Invest       Date:  2018-11-21       Impact factor: 4.256

3.  The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy.

Authors:  Gianluca Trifirò; Fabrizio Parrino; Valeria Pizzimenti; Francesco Giorgianni; Janet Sultana; Marco Muscianisi; Chiara Troncone; Daniele U Tari; Vincenzo Arcoraci; Domenico Santoro; Giusi Russo; Viviana Lacava; Achille P Caputi
Journal:  Clin Drug Investig       Date:  2016-03       Impact factor: 2.859

Review 4.  Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.

Authors:  Merlin C Thomas; Mark E Cooper; Paul Zimmet
Journal:  Nat Rev Nephrol       Date:  2015-11-10       Impact factor: 28.314

5.  Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.

Authors:  David Flood; Pablo Garcia; Kate Douglas; Jessica Hawkins; Peter Rohloff
Journal:  BMJ Open       Date:  2018-01-21       Impact factor: 2.692

Review 6.  Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia.

Authors:  Guido Gembillo; Ylenia Ingrasciotta; Salvatore Crisafulli; Nicoletta Luxi; Rossella Siligato; Domenico Santoro; Gianluca Trifirò
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

Review 7.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

Review 8.  Cardiovascular disease in diabetes, beyond glucose.

Authors:  Robert H Eckel; Karin E Bornfeldt; Ira J Goldberg
Journal:  Cell Metab       Date:  2021-07-21       Impact factor: 31.373

9.  Resting Heart Rate Does Not Predict Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients.

Authors:  Vendula Bartáková; Linda Klimešová; Katarína Kianičková; Veronika Dvořáková; Denisa Malúšková; Jitka Řehořová; Jan Svojanovský; Jindřich Olšovský; Jana Bělobrádková; Kateřina Kaňková
Journal:  J Diabetes Res       Date:  2015-12-28       Impact factor: 4.011

10.  Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: a retrospective cohort study.

Authors:  Yu-Hsuan Li; Wayne H-H Sheu; I-Te Lee
Journal:  BMJ Open       Date:  2018-07-25       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.